John Furey
Directeur/Membre du Conseil chez ADAPTIMMUNE THERAPEUTICS PLC
Fortune : - $ au 30/04/2024
Profil
John P.
Furey is currently the Chief Executive Officer & Director at Imvax, Inc., an Independent Director at Sensorion SA, and an Independent Non-Executive Director at Adaptimmune Therapeutics Plc.
Previously, he worked as an Analyst at PanAgora Asset Management, Inc., Senior Vice President at Baxalta, Inc., General Manager-Vaccine Business Unit at Pfizer Pharmaceuticals Ltd., and Chief Operating Officer at Spark Therapeutics, Inc. He holds an undergraduate degree from Trinity College Dublin and an MBA from Erivan K.
Haub School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de John Furey
| Sociétés | Poste | Début |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur/Membre du Conseil | 05/07/2018 |
| SENSORION | Directeur/Membre du Conseil | 01/09/2019 |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA. | Directeur Général | 10/09/2019 |
Anciens postes connus de John Furey
| Sociétés | Poste | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Directeur des opérations | 31/12/2018 |
| BAXALTA INC | Corporate Officer/Principal | 01/06/2016 |
PanAgora Asset Management, Inc.
 PanAgora Asset Management, Inc. Investment ManagersFinance PanAgora Asset Management, Inc. (PAM) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1989 and is a subsidiary of PanAgora Holdings, Inc., ultimately held by Power Corp. of Canada (TSE: POW) in Canada. PAM is the sponsor and investment manager for certain private unregistered investment pools, such as funds organized under US tax-qualified group trusts, domestic private funds organized as limited liability companies, and offshore private funds organized as Cayman Islands exempted companies. They also provide investment advisory services to institutional separate account clients. | Analyst-Equity | 31/12/2009 |
Pfizer Pharmaceuticals Ltd.
 Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Huizhi Pharmaceutical (Dalian) Co., Ltd. is a pharmaceutical manufacturing company in China. It is a subsidiary compnay of Pfizer, Inc. The company was founded in 1980 and is headquartered in Beijing, CN. | Corporate Officer/Principal | - |
Formation de John Furey
| Trinity College Dublin | Undergraduate Degree |
| Erivan K. Haub School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| SENSORION | Health Technology |
| Entreprise privées | 5 |
|---|---|
PanAgora Asset Management, Inc.
PanAgora Asset Management, Inc. Investment ManagersFinance PanAgora Asset Management, Inc. (PAM) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1989 and is a subsidiary of PanAgora Holdings, Inc., ultimately held by Power Corp. of Canada (TSE: POW) in Canada. PAM is the sponsor and investment manager for certain private unregistered investment pools, such as funds organized under US tax-qualified group trusts, domestic private funds organized as limited liability companies, and offshore private funds organized as Cayman Islands exempted companies. They also provide investment advisory services to institutional separate account clients. | Finance |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Pfizer Pharmaceuticals Ltd.
Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Huizhi Pharmaceutical (Dalian) Co., Ltd. is a pharmaceutical manufacturing company in China. It is a subsidiary compnay of Pfizer, Inc. The company was founded in 1980 and is headquartered in Beijing, CN. | Health Technology |
ImVax, Inc.
ImVax, Inc. BiotechnologyHealth Technology ImVax, Inc. provides healthcare services. The company was founded in 2015 and is headquartered in Philadelphia, PA. | Health Technology |
